The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
KRAS mutations in colorectal cancer patients in Italy: Results from the KRAS aKtive program.
A. Marchetti
No relevant relationships to disclose
C. Pinto
No relevant relationships to disclose
G. L. Taddei
No relevant relationships to disclose
G. Troncone
No relevant relationships to disclose
A. Russo
No relevant relationships to disclose
G. Fontanini
No relevant relationships to disclose
L. M. Larocca
No relevant relationships to disclose
M. Mottolese
No relevant relationships to disclose
G. Giannini
No relevant relationships to disclose
L. Ruco
No relevant relationships to disclose
E. Roz
No relevant relationships to disclose
A. Scarpa
No relevant relationships to disclose
G. Calabrese
No relevant relationships to disclose
B. Bortesi
No relevant relationships to disclose
S. Vaccarella
No relevant relationships to disclose
A. Cossu
No relevant relationships to disclose
V. Ludovini
No relevant relationships to disclose
N. Normanno
No relevant relationships to disclose